About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
ACS Infectious Diseases
›
top-articles
ACS Infectious Diseases
4.7
(top 5%)
impact factor
1.5K
(top 20%)
papers
28.8K
(top 10%)
citations
66
(top 10%)
h
-index
4.8
(top 10%)
impact factor
2.0K
all documents
32.6K
doc citations
98
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
ACS Infectious Diseases
2015
442
2
Quaternary Ammonium Compounds: An Antimicrobial Mainstay and Platform for Innovation to Address Bacterial Resistance
ACS Infectious Diseases
2015
441
3
Therapeutic Potential of Spirooxindoles as Antiviral Agents
ACS Infectious Diseases
2016
350
4
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
ACS Infectious Diseases
2016
265
5
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential
ACS Infectious Diseases
2020
252
6
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease
ACS Infectious Diseases
2020
239
7
Evaluation of Ebola Virus Inhibitors for Drug Repurposing
ACS Infectious Diseases
2015
209
8
Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients
ACS Infectious Diseases
2020
200
9
Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of β-Hairpin Peptides
ACS Infectious Diseases
2016
191
10
Developments in Glycopeptide Antibiotics
ACS Infectious Diseases
2018
185
11
Helping Chemists Discover New Antibiotics
ACS Infectious Diseases
2015
176
12
The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?
ACS Infectious Diseases
2017
166
13
A Comparison of Optical, Electrochemical, Magnetic, and Colorimetric Point-of-Care Biosensors for Infectious Disease Diagnosis
ACS Infectious Diseases
2018
154
14
New Perspectives in Biofilm Eradication
ACS Infectious Diseases
2018
147
15
A New-Class Antibacterial—Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
ACS Infectious Diseases
2015
140
16
Synergistic Photothermal and Antibiotic Killing of Biofilm-Associated
Staphylococcus aureus
Using Targeted Antibiotic-Loaded Gold Nanoconstructs
ACS Infectious Diseases
2016
139
17
Rational Design of Single-Chain Polymeric Nanoparticles That Kill Planktonic and Biofilm Bacteria
ACS Infectious Diseases
2017
134
18
Surface-Enhanced Raman Spectroscopy-Based Sandwich Immunoassays for Multiplexed Detection of Zika and Dengue Viral Biomarkers
ACS Infectious Diseases
2017
134
19
Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-Line Antibiotics against Multidrug-Resistant Gram-Negative Bacteria
ACS Infectious Diseases
2015
124
20
Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design
ACS Infectious Diseases
2019
123
21
Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin
ACS Infectious Diseases
2021
122
22
Solving the Antibiotic Crisis
ACS Infectious Diseases
2015
119
23
Zika Virus Genomic RNA Possesses Conserved G-Quadruplexes Characteristic of the Flaviviridae Family
ACS Infectious Diseases
2016
117
24
Getting Drugs into Gram-Negative Bacteria: Rational Rules for Permeation through General Porins
ACS Infectious Diseases
2018
117
25
Anti-SARS-CoV-2 Potential of Artemisinins In Vitro
ACS Infectious Diseases
2020
117
26
Current and Perspective Diagnostic Techniques for COVID-19
ACS Infectious Diseases
2020
116
27
Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in
Mycobacterium tuberculosis
Infected C3HeB/FeJ Mice
ACS Infectious Diseases
2016
111
28
Nanomaterials for the Treatment of Bacterial Biofilms
ACS Infectious Diseases
2016
111
29
Comparative Analysis of Primer–Probe Sets for RT-qPCR of COVID-19 Causative Virus (SARS-CoV-2)
ACS Infectious Diseases
2020
111
30
Prediction of Drug Penetration in Tuberculosis Lesions
ACS Infectious Diseases
2016
110
31
Human Milk Oligosaccharides Exhibit Antimicrobial and Antibiofilm Properties against Group B
Streptococcus
ACS Infectious Diseases
2017
110
32
Recent Innovations in Bacterial Infection Detection and Treatment
ACS Infectious Diseases
2021
106
33
Potassium Iodide Potentiates Broad-Spectrum Antimicrobial Photodynamic Inactivation Using Photofrin
ACS Infectious Diseases
2017
105
34
Multitarget Approaches against Multiresistant Superbugs
ACS Infectious Diseases
2020
103
35
Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase
ACS Infectious Diseases
2015
100
36
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against
Staphylococcus aureus
Gyrase
ACS Infectious Diseases
2019
99
37
Exhaled Volatile Organic Compounds of Infection: A Systematic Review
ACS Infectious Diseases
2017
96
38
Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2?
ACS Infectious Diseases
2020
96
39
Bicarbonate Alters Bacterial Susceptibility to Antibiotics by Targeting the Proton Motive Force
ACS Infectious Diseases
2018
92
40
Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies
ACS Infectious Diseases
2020
92
41
Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes
ACS Infectious Diseases
2018
91
42
Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump
ACS Infectious Diseases
2017
88
43
Engineered Probiotic for the Inhibition of
Salmonella
via Tetrathionate-Induced Production of Microcin H47
ACS Infectious Diseases
2018
87
44
Kill the Real with the Fake: Eliminate Intracellular
Staphylococcus aureus
Using Nanoparticle Coated with Its Extracellular Vesicle Membrane as Active-Targeting Drug Carrier
ACS Infectious Diseases
2019
87
45
Structure–Function Profile of MmpL3, the Essential Mycolic Acid Transporter from
Mycobacterium tuberculosis
ACS Infectious Diseases
2016
86
46
Liposomes for Antibiotic Encapsulation and Delivery
ACS Infectious Diseases
2020
86
47
High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria
ACS Infectious Diseases
2016
84
48
Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis
ACS Infectious Diseases
2016
83
49
Slippery Liquid-Infused Porous Surfaces that Prevent Bacterial Surface Fouling and Inhibit Virulence Phenotypes in Surrounding Planktonic Cells
ACS Infectious Diseases
2016
83
50
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis
ACS Infectious Diseases
2017
83
site/software ©
exaly
; All materials licenced under
CC by-SA
.